Backtracking RAS mutations in high hyperdiploid childhood acute lymphoblastic leukemia

Area of Science:

• Pediatric Oncology
• Cancer Genetics
• Molecular Biology

Background:

• High hyperdiploidy is the most frequent genetic subtype of childhood acute lymphoblastic leukemia (ALL).
• This subtype is characterized by 51-68 chromosomes, resulting from a single prenatal mitotic error.
• RAS mutations are common in various cancers, but their role in high hyperdiploid ALL is not fully understood.

Purpose of the Study:

• To investigate the frequency and timing of RAS mutations in high hyperdiploid childhood ALL.
• To determine if RAS mutations contribute to the leukemic phenotype in this subtype.
• To explore the natural history of high hyperdiploid leukemia.

Main Methods:

• Screening for RAS mutations in 517 acute childhood leukemias using PCR-restriction enzyme-mediated Taqman quantitative PCR.
• Assessing prenatal KRAS mutations in 14 patients.
• Investigating IGH rearrangements in RAS-positive patients to backtrack clonal origin.

Main Results:

• RAS mutations were found in 30% of high hyperdiploid ALL cases, significantly higher than other subtypes (10%).
• No evidence of prenatal KRAS mutations was detected.
• IGH rearrangements indicated a prenatal origin for the leukemia clone in RAS-positive patients.
• RAS mutations were not significantly associated with parental smoking.

Conclusions:

• High hyperdiploid leukemia likely arises from a prenatal genetic event (mitotic catastrophe).
• Postnatal RAS mutations are acquired later, contributing to the development of the leukemic phenotype.
• This suggests a two-step model for the pathogenesis of high hyperdiploid ALL.